CASE STUDY: Metastatic Adenocarcinoma of Unknown Primary
The Caris Molecular Tumor Board (CMTB) works directly with oncologists to interpret molecular findings and discuss treatment strategies for difficult-to-treat cases. Read how the CMTB approached a patient with a metastatic adenocarcinoma of unknown primary. To view or download the case study please click here or on either of the corresponding pages below.
